MedPath

Prospective Trial of the Effect of Preoperative Forced-air Warming on Perioperative Body Temperature Following Neuraxial Anesthesia in Total Hip Arthroplasty Patients

Phase 4
Terminated
Conditions
Perioperative Hypothermia
Interventions
Device: Bair-Paws Warming Device
Device: Bair-Hugger Warming Device
Registration Number
NCT01626690
Lead Sponsor
University of Wisconsin, Madison
Brief Summary

The purpose of this study is to determine if placement of a forced-air warming device prior to institution of regional anesthesia improves perioperative temperature control in patients undergoing total hip arthroplasty.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
100
Inclusion Criteria
  • patients undergoing total hip arthroplasty under neuraxial anesthesia,
  • age 55-85,
  • BMI 18-40
Exclusion Criteria
  • allergy to local anesthetics,
  • patients electing to have general anesthesia for their total hip arthroplasty,
  • pregnancy,
  • prisoners,
  • patients unable to give informed consent,
  • English as a second language,
  • active infectious or febrile illness (measured temperature > 37.5 degrees Celsius).

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Pre-WarmingBair-Paws Warming Device-
ControlBair-Hugger Warming Device-
Primary Outcome Measures
NameTimeMethod
Patient Temperature at the Time of Incision as Measured by SpotOn (3M) Temperature Monitoring System..The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

Temporal artery temperature readings (in degrees celsius) will be obtained at the time of incision and every 30 minutes while in the OR.

Secondary Outcome Measures
NameTimeMethod
Patient Temperature on Arrival to Recovery Room as Measured by SpotOn (3M) Temperature Monitoring System.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).
Patient Temperature Prior to Entering OR as Measured by SpotOn (3M) Temperature Monitoring System.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).
Intraoperative Blood Loss.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

Intraoperative blood loss in mL's.

Incidence of Perioperative Cardiac Events.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

Incidence of perioperative arrhythmias or myocardial ischemia.

Temporal Artery Verus SpotOn (3M) Temperature Readings.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

Temperature with temporal artery thermometer and SpotOn temperature monitoring device (3M) at time of incision.

Incidence of Postoperative Shivering in Recovery Room.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).
Patient Temperature 30 Minutes Following Incision as Measured by SpotOn (3M) Temperature Monitoring System.The treatment period starts with the patient consenting to the study and application of preoperative forced-air warming device and ends when the patient leaves the PACU (average 4-8 hours following enrollment).

Trial Locations

Locations (1)

University of Wisconsin School of Medicine and Public Health

🇺🇸

Madison, Wisconsin, United States

© Copyright 2025. All Rights Reserved by MedPath